Welcome to General Directorate of Pharmaceutical Affairs (GDPA)

Healthier individuals and community can play more active roles in construction and economic development of their countries. Technically and financially, medicines and other medical supplies and commodities constitute one of the main components of health services.

The vision of the MoPH is stated as “Better health for all Afghans in order to contribute to economic and social development,” and the mission statement is a commitment to ensuring the accelerated implementation of quality health care. The MoPH aims to achieve equitable, affordable, and sustainable quality support services, including those for pharmaceuticals. The provision of appropriate essential medicines at each level of the public health system is one of the seven core elements of the Basic Package of Health Services (BPHS) for Afghanistan.

To safeguard the public and, in particular, to ensure quality of clinical services, the MoPH has been focusing on reviewing, developing, and enforcing relevant legal and regulatory instruments and policies that govern health and health-related work. To achieve these objectives, cooperation, collaboration and sincere efforts of all pharmaceutical sector stakeholders is highly essential.

The General Directorate of Pharmaceutical Affairs (GDPA) is the only pharmaceutical regulatory body in the country. GDPA will continue to provide the functions of the National Medicines Regulatory Authority.

Vision of the General Directorate of Pharmaceutical Affaires (GDPA): All the country needs in terms of pharmaceutical and health products and also standard pharmaceutical services are met.

The GDPA mission is: to lead, initiate, and manage all programs and system relevant to pharmaceutical and to ensure that all pharmaceutical needs at the country level are met.